On the contrary to observations of prostatic schistosomiasis infection progressing over time as represented by a patient with prostate adenocarcinoma and high prostate-specific antigen levels (11.59 ng/mL) reported by Metrogos et. al in 2017 [36], we observed insignificant lower prostate-specific antigen levels of among participants with history of schistosomiasis infection compared to those without history of schistosomiasis infection. This evidence concerns the gene KLK3 and prostate adenocarcinoma.